Filter posts

Value Assessment Tools that take “Precision” out of “Precision Medicine” are Harmful to Pati...

The conversation about health care costs is front and center in Washington, and new data …

A New Approach to Assessing Value in Health Care

It’s an important and exciting time in the biotech industry. Spending on prescription drugs has …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

MassBio Releases Statement Following Cost Trends Hearings

MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on …